Search Results 771-780 of 18360 for Hepatitis b

1. Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma (KarMMa) - Mayo Clinic

   ... hepatitis B virus (HBV):. Subjects who are hepatitis B surface antigen (HBsAg) negative and HBV viral DNA negative are eligible;; Subjects who had hepatitis B ...

2. Study to Evaluate the Safety and Effectiveness of Axicabtagene Ciloleucel in Combination With Utomilumab in Adults With Relapsed/Refractory Large B-cell Lymphoma - Mayo Clinic

   History of human immunodeficiency virus (HIV) infection or acute or chronic active hepatitis B or C infection. Subjects with history of hepatitis infection ...

3. Surgery - Doctors - Mayo Clinic

   problems, Esophageal varices, Hepatitis C, Primary sclerosing cholangitis, Hepatitis B, Cholangiocarcinoma, Portal hypertension, Hemochromatosis, Alcoholic ...

4. A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia - Mayo Clinic

   Subject who is seropositive for or active viral infection with hepatitis B virus (HBV) (hepatitis B surface antigen [HBsAg] positive and/or detectable viral DNA) ...

5. Dissecting the Genetic Environment Contributions of Autoimmune Liver Disease - Mayo Clinic

   ... hepatitis (AIH), overlap AIH with Primary Biliary Cirrhosis (AIH-PBC), overlap AIH with Primary Sclerosing Cholangitis (AIH-PSC), and drug-induced ...

6. Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies - Mayo Clinic

   History of active hepatitis or positive serology for hepatitis. Participating Mayo Clinic locations. Study statuses change often. Please contact the study ...

7. Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma - Mayo Clinic

   No active viral infection with human immunodeficiency virus (HIV), hepatitis B, or hepatitis C. Those who are seropositive (e.g., hepatitis B core antibody ...

8. A Study to Evaluate Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant - Mayo Clinic

   At risk for HBV reactivation is defined as hepatitis B surface antigen positive or anti-hepatitis B core antibody positive. Previous test results obtained ...

9. B-cell lymphoma - Doctors and departments - Mayo Clinic

   Find out more about the symptoms, diagnosis and treatment of this type of non-Hodgkin lymphoma.

10. A Registry for Participants with Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment with a Sofosbuvir-Based Regimen without Interferon for Chronic Hepatitis C Infection - Mayo Clinic

    ... Hepatitis C Infection. Print details. Share; Facebook · Twitter. Overview ... hepatitis C virus (HCV) study or commercially at selected sites. Once enrolled ...